Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Imagin Medical Announces Stock Option Grant

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Krystal Biotech, Inc.

ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

NanoVibronix Announces Closing of $3.2 Million Private Placement

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Athenex Announces U.S. FDA Allowance of Investigational New Drug Application for PT01 (Pegtomarginase)

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Athenex Inc.

Axsome Therapeutics Initiates GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Axsome Therapeutics, Inc.

Pluristem Completes Transition Period of Co-CEO Structure Yaky Yanay appointed as Chief Executive Officer and Zami Aberman appointed as Executive Chairman of the Board

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Pluristem Therapeutics Inc

Syneos Health Introduces FSP 360 – Next Evolution Model Provides Customers Broadest Range of Functional Service Provider Solutions

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Syneos Health, Inc

Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Innovate Biopharmaceuticals, Inc.

Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Applied Therapeutics Inc.

Trevena Announces Publication of APOLLO-2 Results in Pain Practice

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Trevena, Inc

CureVac Welcomes Two Members to its Supervisory Board

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  CureVac AG

Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Axovant Announces Poster Presentations at the 5th Congress of the European Academy of Neurology

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Axovant Sciences Ltd.

Share buy-back week 25/2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Coloplast A/S

Transactions under Novozymes’ stock buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Novozymes A/S

Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Minerva Neurosciences Inc.

Blueberries Announces Appointment of Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019

Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims

Read more ››
By: Nasdaq / GlobenewsWire - 24 Jun 2019
Related companies:  Progenics Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑